Carl LeBel, PhD

phase_1phase_2

FX-322 (Four Doses)

phase_2

FX-345

phase_1

FX-322 (One Dose)

phase_2

FX-322 (Two Doses)

phase_2

First in Human Safety Study of FX-345 in Adults With Sensorineural Hearing Loss

5 unique interventions1 categories

Analytics

Trial Phases

Phase 13

Phase 22

Trial Status

Completed4

Terminated1

Role Distribution

Other Roles5

Activity Timeline

Clinical Trials (5)

NCT05664100Phase 1Terminated

Hearing Loss, Sensorineural

StudydirectorStart date: 2022-12-15

NCT05086276Phase 2Completed

FX-322 in Adults With Acquired Sensorineural Hearing Loss

Hearing Loss, SensorineuralNoise Induced Hearing LossSudden Hearing Loss

StudydirectorStart date: 2021-10-12

NCT04629664Phase 1Completed

FX-322 in Adults With Severe Sensorineural Hearing Loss

Hearing Loss, SensorineuralNoise Induced Hearing LossSudden Hearing Loss

StudydirectorStart date: 2020-11-02

NCT04601909Phase 1Completed

FX-322 in Adults With Age-Related Sensorineural Hearing Loss

Hearing Loss, SensorineuralNoise Induced Hearing LossPresbycusis+1 more

StudydirectorStart date: 2020-09-17

NCT04120116Phase 2Completed

FX-322 in Adults With Stable Sensorineural Hearing Loss

Noise Induced Hearing LossSensorineural Hearing LossSudden Sensorineural Hearing Loss

StudydirectorStart date: 2019-10-04

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Hearing Loss, Sensorineural5 Hearing Loss, Noise-Induced4 Hearing Loss, Sudden3 Presbycusis1 Sudden Sensorineural Hearing Loss1

Affiliations

Frequency Therapeutics

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Andrea Vambutas, MD

Northwell Health

Hearing Loss, SuddenHearing Loss, Sensorineural

Shared therapeutic areas:

Similarity Score12%

Yu-Hsiang Wu, PhD

University of Iowa

4 trials

Shared therapeutic areas:

PresbycusisHearing Loss, Sensorineural

Similarity Score12%

Shan Sun

Eye & ENT Hospital of Fudan University

4 trials

Shared therapeutic areas:

Sichao Liang, MA

Beijing Tsinghua Changung Hospital

1 trials

Shared therapeutic areas:

Hearing Loss, Sudden

Mu He, MD

Beijing Tsinghua Changung Hospital

1 trials

Shared therapeutic areas:

Hearing Loss, Sudden

Hearing Loss, Noise-Induced

Jonathan Kil, MD

Sound Pharmaceuticals, Inc.

5 trials

Shared therapeutic areas:

Pamela Souza, PhD

Northwestern University

4 trials

Shared therapeutic areas:

Kevin Seitz-Paquette, AuD

Sonova AG

Shared therapeutic areas:

David L. Woods, PhD

VA Northern California HCS

Shared therapeutic areas:

Juanjuan Gao, MD

Beijing Tsinghua Changung Hospital

1 trials

Shared therapeutic areas:

Hearing Loss, Sudden